ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Decreasing sample size in primary prevention studies: A potential role for coronary artery calcium score [letter] (2015)
Bittencourt, Márcio Sommer; Blankstein, Ron; Nasir, Khurram
Fonte: European Journal of Preventive Cardiology. Unidade: HU
Assuntos: ARTERIOSCLEROSE CORONÁRIA, CÁLCIO (METABOLISMO), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer e BLANKSTEIN, Ron e NASIR, Khurram. Decreasing sample size in primary prevention studies: A potential role for coronary artery calcium score [letter]. European Journal of Preventive Cardiology. London: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1177/2047487314568022. Acesso em: 01 nov. 2024. , 2015
APA
Bittencourt, M. S., Blankstein, R., & Nasir, K. (2015). Decreasing sample size in primary prevention studies: A potential role for coronary artery calcium score [letter]. European Journal of Preventive Cardiology. London: Hospital Universitário, Universidade de São Paulo. doi:10.1177/2047487314568022
NLM
Bittencourt MS, Blankstein R, Nasir K. Decreasing sample size in primary prevention studies: A potential role for coronary artery calcium score [letter] [Internet]. European Journal of Preventive Cardiology. 2015 ; 22( 7): 931.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1177/2047487314568022
Vancouver
Bittencourt MS, Blankstein R, Nasir K. Decreasing sample size in primary prevention studies: A potential role for coronary artery calcium score [letter] [Internet]. European Journal of Preventive Cardiology. 2015 ; 22( 7): 931.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1177/2047487314568022
Trabalho de evento-resumo periodico
Implications of coronary artery calcium score on sample size calculations in cardiovascular primary prevention trials: the Multi-Ethnic Study of Atherosclerosis (MESA) (2014)
Bittencourt, Márcio Sommer; Blankstein, Ron; Patel, Jaideep; Blaha, Michael; Hulten, Edward; Blumenthal, Roger; Shaw, Leslee; Liu, Songtao; Eng, John; Agatston, Arthur; Budoff, Matthew; Nasir, Khurram
Fonte: Journal of the American College of Cardiology. Nome do evento: Cardiovascular Summit TCTAP 2014. Unidade: HU
Assuntos: ARTERIOSCLEROSE, CÁLCIO (METABOLISMO), DOENÇAS CARDIOVASCULARES (PREVENÇÃO E CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer et al. Implications of coronary artery calcium score on sample size calculations in cardiovascular primary prevention trials: the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2014
APA
Bittencourt, M. S., Blankstein, R., Patel, J., Blaha, M., Hulten, E., Blumenthal, R., et al. (2014). Implications of coronary artery calcium score on sample size calculations in cardiovascular primary prevention trials: the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo.
NLM
Bittencourt MS, Blankstein R, Patel J, Blaha M, Hulten E, Blumenthal R, Shaw L, Liu S, Eng J, Agatston A, Budoff M, Nasir K. Implications of coronary artery calcium score on sample size calculations in cardiovascular primary prevention trials: the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American College of Cardiology. 2014 ; 63( 12 suppl.): A1159.[citado 2024 nov. 01 ]
Vancouver
Bittencourt MS, Blankstein R, Patel J, Blaha M, Hulten E, Blumenthal R, Shaw L, Liu S, Eng J, Agatston A, Budoff M, Nasir K. Implications of coronary artery calcium score on sample size calculations in cardiovascular primary prevention trials: the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American College of Cardiology. 2014 ; 63( 12 suppl.): A1159.[citado 2024 nov. 01 ]
Trabalho de evento-resumo periodico
Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA) (2014)
Nasir, Khurram; Bittencourt, Márcio Sommer; Blaha, Michael J; Budoff, Matthew J; Blankstein, Ron; Agatston, Arthur; Sibley, Christopher T; Shaw, Leslee J; Blumenthal, Roger; Krumholz, Harlan M
Fonte: Circulation. Nome do evento: Scientific Sessions 2014. Unidade: HU
Assuntos: ARTERIOSCLEROSE CORONÁRIA, CÁLCIO (METABOLISMO), DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, ESTUDOS LONGITUDINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASIR, Khurram et al. Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. Dallas: Hospital Universitário, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2014
APA
Nasir, K., Bittencourt, M. S., Blaha, M. J., Budoff, M. J., Blankstein, R., Agatston, A., et al. (2014). Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. Dallas: Hospital Universitário, Universidade de São Paulo.
NLM
Nasir K, Bittencourt MS, Blaha MJ, Budoff MJ, Blankstein R, Agatston A, Sibley CT, Shaw LJ, Blumenthal R, Krumholz HM. Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2014 ; no 2014( suppl. 1):[citado 2024 nov. 01 ]
Vancouver
Nasir K, Bittencourt MS, Blaha MJ, Budoff MJ, Blankstein R, Agatston A, Sibley CT, Shaw LJ, Blumenthal R, Krumholz HM. Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2014 ; no 2014( suppl. 1):[citado 2024 nov. 01 ]
Artigo de periodico
Utility of cardiovascular imaging to refine cardiovascular disease (CVD) risk assessment (2014)
Bittencourt, Márcio Sommer; Hulten, Edward A; Nasir, Khurram; Blankstein, Ron
Fonte: Current Cardiovascular Risk Reports. Unidade: HU
Assuntos: DOENÇAS CARDIOVASCULARES (PREVENÇÃO E CONTROLE), CÁLCIO (METABOLISMO), AVALIAÇÃO DE RISCO, DIAGNÓSTICO POR IMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer et al. Utility of cardiovascular imaging to refine cardiovascular disease (CVD) risk assessment. Current Cardiovascular Risk Reports, v. 8, n. 4, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12170-014-0378-5. Acesso em: 01 nov. 2024.
APA
Bittencourt, M. S., Hulten, E. A., Nasir, K., & Blankstein, R. (2014). Utility of cardiovascular imaging to refine cardiovascular disease (CVD) risk assessment. Current Cardiovascular Risk Reports, 8( 4). doi:10.1007/s12170-014-0378-5
NLM
Bittencourt MS, Hulten EA, Nasir K, Blankstein R. Utility of cardiovascular imaging to refine cardiovascular disease (CVD) risk assessment [Internet]. Current Cardiovascular Risk Reports. 2014 ; 8( 4):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s12170-014-0378-5
Vancouver
Bittencourt MS, Hulten EA, Nasir K, Blankstein R. Utility of cardiovascular imaging to refine cardiovascular disease (CVD) risk assessment [Internet]. Current Cardiovascular Risk Reports. 2014 ; 8( 4):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s12170-014-0378-5

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em

Afiliação dos autores externos não normalizada